Articles tagged with Therapeutic Cloning
Researchers have developed an automated calling algorithm for determining B and T cell clonality from NGS data with greater sensitivity than previous models. The new model increases the assay's sensitivity in detecting clonality, allowing for more accurate diagnosis and monitoring of lymphoproliferative disorders.
Researchers have used genetic modification to create cattle with a gene resistant to the bacteria causing bovine tuberculosis. This advance supports the development of genetically modified animals as an effective tool against deadly bacterial infections in the livestock industry.
A study found that amino acid concentrations were reduced in cloned embryos compared to in vitro fertilized pregnancies. This may explain developmental abnormalities and complications leading to embryo death. The findings highlight the importance of researching maternal-embryo interactions.
Researchers at Memorial Sloan-Kettering Cancer Center have successfully used therapeutic cloning to treat Parkinson's disease in mice. The method involves generating customized dopamine neurons from the patient's own skin cells and transplanting them into the mouse, resulting in neurological improvement.
Leading researchers, including Gerald Schatten, explore the potential of stem cells from therapeutic cloning for treating various diseases. However, concerns over safety, efficacy, and ethical implications remain a topic of debate.
Researchers at Seoul National University successfully produced genetically identical stem cells through somatic cell nuclear transfer (SCNT). The breakthrough holds promise for treating a large number of currently untreatable conditions, including inherited diseases.